Conversely, in pancreatic cancer cells, MYEOV expression is upregulated and promotes the downregulation of MXD4 and CASTOR2, resulting in the activation of c-Myc and mTORC1 and tumor progression. This evidence concerns the gene MXD4 and familial pancreatic carcinoma.